Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998–2012

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 4, 2015, Pages 821-830

  van Gent, M ^a   Heuvelman, C J ^a   van der Heide, H G ^a   Hallander, H O ^b   Advani, A ^b   Guiso, N ^c   Wirsing von Konig C H ^d   Vestrheim, D F ^e   Dalby, T ^f   Fry, N K ^g   Pierard, D ^h   Detemmerman, L ^h   Zavadilova, J ⁱ   Fabianova, K ⁱ   Logan, C ^j   Habington, A ^j   Byrne, M ^j   Lutynska A ^k   Mosiej, E ^k   Pelaz, C ^l   Grondahl Yli Hannuksela K ^m   Barkoff, A M ^m   Mertsola, J ⁿ   Economopoulou, A ^o   He, Q ^m   Mooi, F R ^a   more..

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b The Swedish National Institute of Public Health   (Sweden)

^c INSTITUT PASTEUR   (France)

^d Helios Klinikum   (Germany)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^f STATENS SERUM INSTITUT   (Denmark)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

ⁱ NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^j OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^k NATIONAL INSTITUTE OF HYGIENE   (Poland)

^l INSTITUTO DE SALUD CARLOS III   (Spain)

^m NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁿ TURKU UNIVERSITY HOSPITAL   (Finland)

^o EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS TOXIN; PERTUSSIS VACCINE; BACTERIAL ANTIGEN;

ARTICLE; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; EUROPEAN; FIMBRIA; GENE FREQUENCY; HUMAN; PERTUSSIS; POLAND; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING; VACCINATION; VARIABLE NUMBER OF TANDEM REPEAT; CLASSIFICATION; EUROPE; GENETIC VARIABILITY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PROMOTER REGION; WHOOPING COUGH;

ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; EUROPE; GENETIC VARIATION; HUMANS; MINISATELLITE REPEATS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PERTUSSIS TOXIN; PROMOTER REGIONS, GENETIC; SEROTYPING; WHOOPING COUGH;

EID: 84925482883     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2297-2     Document Type: Article

References (56)

1. de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR (2011) Pertussis: a matter of immune modulation. FEMS Microbiol Rev 35:441–474
2. Octavia S, Sintchenko V, Gilbert GL, Lawrence A, Keil AD, Hogg G, Lan R (2012) Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008–2010. J Infect Dis 205:1220–1224
3. Dudman SG, Trøseid M, Jonassen TØ, Steinbakk M (2006) Whooping cough—an increasing problem in Norway. Tidsskr Nor Laegeforen 126:305–308
4. Stefanoff P, Paradowska-Stankiewicz IA, Lipke M, Karasek E, Rastawicki W, Zasada A, Samuels S, Czajka H, Pebody RG (2014) Incidence of pertussis in patients of general practitioners in Poland. Epidemiol Infect 142:714–723
5. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, de Greeff SC, Diavatopoulos D, Teunis P, Nagelkerke N, Mertsola J (2009) Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15:1206–1213
6. Amirthalingam G, Gupta S, Campbell H (2013) Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveill 18(38). pii: 20587
7. Queenan AM, Cassiday PK, Evangelista A (2013)Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 368:583–584
8. Halperin SA (2007) The control of pertussis—2007 and beyond. N Engl J Med 356:110–113
9. van der Maas NA, Mooi FR, de Greeff SC, Berbers GA, Spaendonck MA, de Melker HE (2013) Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine 31:4541–4547
10. Cherry JD (2005) The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 115:1422–1427
11. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P (2011) Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 11:557–570
12. Mooi FR, van der Maas NA, de Melker HE (2014) Pertussis resurgence: waning immunity and pathogen adaptation—two sides of the same coin. Epidemiol Infect 142:685–694
13. Hegerle N, Guiso N (2013) Epidemiology of whooping cough & typing of Bordetella pertussis. Future Microbiol 8:1391–1403
14. Berbers GA, de Greeff SC, Mooi FR (2009) Improving pertussis vaccination. Hum Vaccin 5:497–503
15. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ (1998) Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 66:670–675
16. Caro V, Bouchez V, Guiso N, Gatti B, Agosti MR, Ayala SE (2007) Pertussis in Argentina and France. Vaccine 25:4335–4339
17. Litt DJ, Neal SE, Fry NK (2009) Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol 47:680–688
18. Advani A, Van der Heide HG, Hallander HO, Mooi FR (2009) Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods 78:297–301
19. Mosiej E, Augustynowicz E, Zawadka M, Dabrowski W, Lutyńska A (2011) Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use. J Clin Microbiol 49:1452–1457
20. Kallonen T, Gröndahl-Yli-Hannuksela K, Elomaa A, Lutyńska A, Fry NK, Mertsola J, He Q (2011) Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infect Genet Evol 11:2034–2042
21. Petersen RF, Dalby T, Dragsted DM, Mooi F, Lambertsen L (2012) Temporal trends in Bordetella pertussis populations, Denmark, 1949–2010. Emerg Infect Dis 18:767–774
22. Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM (2012) Population diversity among Bordetella pertussis isolates, United States, 1935–2009. Emerg Infect Dis 18:1248–1255
23. van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Mooi FR (2012) Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One 7:e46407
24. Shuel M, Jamieson FB, Tang P, Brown S, Farrell D, Martin I, Stoltz J, Tsang RS (2013) Genetic analysis of Bordetella pertussis in Ontario, Canada reveals one predominant clone. Int J Infect Dis 17:e413–e417
25. Miyaji Y, Otsuka N, Toyoizumi-Ajisaka H, Shibayama K, Kamachi K (2013) Genetic analysis of Bordetella pertussis isolates from the 2008–2010 pertussis epidemic in Japan. PLoS One 8:e77165
26. de Gouw D, Hermans PW, Bootsma HJ, Zomer A, Heuvelman K, Diavatopoulos DA, Mooi FR (2014) Differentially expressed genes in bordetella pertussis strains belonging to a lineage which recently spread globally. PLoS One 9:e84523
27. Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He Q, van der Heide HG, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan R, Lutyłska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RS, Xu Y, Yao SM, Zhang S, Parkhill J, Mooi FR (2014) Global population structure and evolution of bordetella pertussis and their relationship with vaccination. MBio 5:e01074
28. Advani A, Gustafsson L, Ahrén C, Mooi FR, Hallander HO (2011) Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine 29:3438–3442
29. van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Kallonen T, He Q, Mertsola J, Advani A, Hallander HO, Janssens K, Hermans PW, Mooi FR (2011)SNP-based typing: a useful tool to study bordetella pertussis populations. PLoS One 6:e20340
30. Lam C, Octavia S, Bahrame Z, Sintchenko V, Gilbert GL, Lan R (2012) Selection and emergence of pertussis toxin promoter ptxP3 allele in the evolution of Bordetella pertussis. Infect Genet Evol 12:492–495
31. Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N (2009) First report and detailed characterization of B. Pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 27:6034–6041
32. Hegerle N, Paris AS, Brun D, Dore G, Njamkepo E, Guillot S, Guiso N (2012) Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect 18:E340–E346
33. Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q (2012) Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol 19:1703–1704
34. Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison MJ, Shang W, Williams MM, Bowden KE, Burgos-Rivera B, Qin X, Messonnier N, Tondella ML (2013) Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 2:119–125
35. Quinlan T, Musser KA, Currenti SA, Zansky SM, Halse TA (2013)Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004–2013. Mol Cell Probes 28:138–140
36. Dinu S, Guillot S, Dragomirescu CC, Brun D, Lazăr S, Vancea G, Ionescu BM, Gherman MF, Bjerkestrand AF, Ungureanu V, Guiso N, Damian M (2014) Whooping cough in South-East Romania: a 1-year study. Diagn Microbiol Infect Dis 78:302–306
37. Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, McIntyre P, Marshall H, Guiso N, Keil AD, Lawrence A, Robson J, Hogg G, Lan R (2014) Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis 20:626–633
38. Zeddeman A, van Gent M, Heuvelman CJ, van der Heide HG, Bart MJ, Advani A, Hallander HO, Wirsing von Konig CH, Riffelman M, Storsaeter J, Vestrheim DF, Dalby T, Krogfelt KA, Fry NK, Barkoff AM, Mertsola J, He Q, Mooi F (2014) Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Euro Surveill 19(33). pii: 20881
39. Tsang RS, Shuel M, Jamieson FB, Drews S, Hoang L, Horsman G, Lefebvre B, Desai S, St-Laurent M (2014)Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years. Int J Infect Dis 28:65–69
40. van Amersfoorth SC, Schouls LM, van der Heide HG, Advani A, Hallander HO, Bondeson K, von König CH, Riffelmann M, Vahrenholz C, Guiso N, Caro V, Njamkepo E, He Q, Mertsola J, Mooi FR (2005) Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol 43:2837–2843
41. Caro V, Njamkepo E, Van Amersfoorth SC, Mooi FR, Advani A, Hallander HO, He Q, Mertsola J, Riffelmann M, Vahrenholz C, Von König CH, Guiso N (2005)Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect 7:976–982
42. Hallander H, Advani A, Riffelmann M, von König CH, Caro V, Guiso N, Mooi FR, Gzyl A, Kaltoft MS, Fry NK, Mertsola J, He Q (2007) Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol 45:3257–3262
43. Advani A, Hallander HO, Dalby T, Krogfelt KA, Guiso N, Njamkepo E, von Könnig CH, Riffelmann M, Mooi FR, Sandven P, Lutynska A, Fry NK, Mertsola J, He Q (2013)Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. J Clin Microbiol 51:422–428
44. Mooi FR, Hallander H, Wirsing von König CH, Hoet B, Guiso N (2000) Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol 19:174–181
45. van Loo IH, Heuvelman KJ, King AJ, Mooi FR (2002) Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 40:1994–2001
46. Schouls LM, van der Heide HG, Vauterin L, Vauterin P, Mooi FR (2004)Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol 186:5496–5505
47. Mooi FR (2010) Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol 10:36–49
48. Mosiej E, Zawadka M, Krysztopa-Grzybowska K, Polak M, Augustynowicz E, Piekarska K, Lutyńska A (2014) Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959–2013. Eur J Clin Microbiol Infect Dis [Epub ahead of print]
49. Zawadka M, Mosiej E, Polak M, Krysztopa-Grzybowska K, Moskała B, Rokosz-Chudziak N, Rabczenko D, Augustynowicz E, Lutyńska A (2014) Consistency of Bordetella pertussis vaccine seed strains and potency of whole-cell pertussis vaccine still in use in Poland. Biologicals 42:123–127
50. Borisova O, Kombarova SY, Zakharova NS, van Gent M, Aleshkin VA, Mazurova I, Mooi FR (2007) Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin Vaccine Immunol 14:234–238
51. Octavia S, Maharjan RP, Sintchenko V, Stevenson G, Reeves PR, Gilbert GL, Lan R (2011) Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. Mol Biol Evol 28:707–715
52. Packard ER, Parton R, Coote JG, Fry NK (2004) Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol 53:355–365
53. Dakic G, Kallonen T, Elomaa A, Pljesa T, Vignjevic-Krastavcevic M, He Q (2010) Bordetella pertussis vaccine strains and circulating isolates in Serbia. Vaccine 28:1188–1192
54. Lipsitch M, O’Hagan JJ (2007) Patterns of antigenic diversity and the mechanisms that maintain them. J R Soc Interface 4:787–802
55. Bart MJ, van Gent M, van der Heide HG, Boekhorst J, Hermans P, Parkhill J, Mooi FR (2010) Comparative genomics of prevaccination and modern Bordetella pertussis strains. BMC Genomics 11:627
56. Hegerle N, Guiso N (2014) Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines 13:1135–1146